Cargando…

Amyloid imaging for dementia in clinical practice

In vivo imaging of brain amyloid using positron emission tomography (PET) scanning is widely used in research studies of dementia, with three amyloid PET ligands being licenced for clinical use. The main clinical use of PET is to help confirm or exclude the likely diagnosis of Alzheimer’s disease in...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Brien, John T., Herholz, Karl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499896/ https://www.ncbi.nlm.nih.gov/pubmed/26170121 http://dx.doi.org/10.1186/s12916-015-0404-6

Ejemplares similares

Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2018)

Amyloid imaging in clinical trials
por: Ossenkoppele, Rik, et al.
Publicado: (2013)

The challenges of COVID‐19 for people with dementia with Lewy bodies and family caregivers
por: Killen, Alison, et al.
Publicado: (2020)

Amyloid imaging in prodromal Alzheimer's disease
por: Ossenkoppele, Rik, et al.
Publicado: (2011)

Imaging Clinical Subtypes and Associated Brain Networks in Alzheimer’s Disease
por: Herholz, Karl
Publicado: (2022)

Beta-amyloid imaging in dementia
por: Chun, Kyung Ah
Publicado: (2018)

Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo
por: Rabinovici, G. D., et al.
Publicado: (2009)

Gene Therapy for Type 1 Diabetes Moves a Step Closer to Reality
por: O’Brien, Timothy
Publicado: (2013)

Reducing the Power of the Alcohol Industry in Trade and Investment Agreement Negotiations Through Improved Global Governance of Alcohol Comment on "What Generates Attention to Health in Trade Policy-Making? Lessons From Success in Tobacco Control and Access to Medicines: A Qualitative Study of Australia and the (Comprehensive and Progressive) Trans-Pacific Partnership"
por: O’Brien, Paula
Publicado: (2021)

Dual-phase [18F]florbetapir in frontotemporal dementia
por: Asghar, Michael, et al.
Publicado: (2018)

Genome empowerment for the Puerto Rican parrot – Amazona vittata
por: O’Brien, Stephen J
Publicado: (2012)

All bleeding matters … but the details may not
por: O’Brien, Sarah H.
Publicado: (2019)

A decade of GigaScience: A perspective on conservation genetics
por: O'Brien, Stephen J
Publicado: (2022)

Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications
por: Laforce, Robert, et al.
Publicado: (2011)

Establishing the Irish Critical Care Trials Group: 'who wins in battle makes many calculations before the battle is fought'
por: O'Brien, Brian, et al.
Publicado: (2008)

Modeling amyloids in bacteria
por: Villar-Piqué, Anna, et al.
Publicado: (2012)

Do amyloid fibrils induce inflammation, or does inflammation generate amyloid fibrils?
por: Rothbard, Jonathan B.
Publicado: (2022)

Driving and dementia: a clinical decision pathway
por: Carter, Kirsty, et al.
Publicado: (2015)

Coming out ahead: the cost effectiveness of external cephalic version using spinal anesthesia
por: O’Brien, James A, et al.
Publicado: (2014)

Conceptualising Long COVID as an episodic health condition
por: Brown, Darren A, et al.
Publicado: (2021)

Strengthening regulatory systems for medicines in a changed world: where do we go from here?
por: O'Brien, Julie, et al.
Publicado: (2021)

Taxonomic species recognition should be consistent
por: O’Brien, Stephen J, et al.
Publicado: (2023)

Competencies and training of radiographers and technologists for PET/MR imaging - a study from the UK MR-PET network
por: Mada, Marius Ovidiu, et al.
Publicado: (2020)

The Genome Russia project: closing the largest remaining omission on the world Genome map
por: Oleksyk, Taras K., et al.
Publicado: (2015)

Preventing pre-eclampsia – are dietary factors the key?
por: Dodd, Jodie M, et al.
Publicado: (2014)

Cyber-attacks are a permanent and substantial threat to health systems: Education must reflect that
por: Niki, O’Brien, et al.
Publicado: (2022)

What Are the Molecular Mechanisms by Which Functional Bacterial Amyloids Influence Amyloid Beta Deposition and Neuroinflammation in Neurodegenerative Disorders?
por: Friedland, Robert P., et al.
Publicado: (2020)

Why are psychiatric imaging methods clinically unreliable? Conclusions and practical guidelines for authors, editors and reviewers
por: Borgwardt, Stefan, et al.
Publicado: (2012)

The COVID-19 Diagnostic Dilemma: a Clinician's Perspective
por: Rogers, Ralph, et al.
Publicado: (2020)

Pandemic Dementia Scarce Resource Allocation
por: Smith, Eric E., et al.
Publicado: (2020)

Amyloid and the Macrophage: It’s All About Local Production of IL-1β
por: Broniowska, Katarzyna A., et al.
Publicado: (2014)

Can novel therapeutics halt the amyloid cascade?
por: Prins, Niels D, et al.
Publicado: (2010)

Jekyll and Hide: The two faces of amyloid β
por: Proft, Juliane, et al.
Publicado: (2012)

Preimplantation genetic testing for familial amyloid polyneuropathy
por: Sousa, Mário
Publicado: (2022)

Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus
por: Anstey, Kaarin J., et al.
Publicado: (2020)

(11)C‐PK11195 PET imaging and white matter changes in Parkinson’s disease dementia
por: Nicastro, Nicolas, et al.
Publicado: (2019)

Thiamine Metabolites and Dementia?
por: Kuller, Lewis H.
Publicado: (2015)

Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
por: Withington, Charles G., et al.
Publicado: (2022)

Championing of dementia in England
por: Abdi, Zeinab, et al.
Publicado: (2012)

Visual cortical excitability in dementia with Lewy bodies
por: Taylor, John-Paul, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bbjoivkm9m071k7m9hqvsn9s5r